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ABSTRACT

DISSECTION OF MACROP HAGE ACTIVATION USING T CELL
HYBRIDOMA DERIVED LYMPHOKINES
William Stewart Futch, M.S.
Medical College of Virginia-Virginia Commonwealth University, 1 9 8 5
Major Director: Lawrence B . Schook, Ph.D.
Macrophage phenotype/function can be modulated by various T-<!ell
lymphokines (LK). The alteration of macrophage phenotype is a result of
LK concentration, duration of exposure, and the level of macrophage
activation when obtained from in vivo sources through elicitation by
either sterile irritants or immune cellular mechanisms. In order to dissect
macrophage activation into discrete signals T cell hybridomas were
constructed by fusing HAT sensitive BW5147 cells with nylon-wool
purified, con A stimulated T cells.
screened for their ability to:

The resulting T cell hybrids were
(a) protect macrophages from the

cytopathic effect of Naegleria; (b) induce class II MHC gene product (Ia
antigen) expression; (c) increase cytostasis and tumoricidal activity; and
(d) alter ectoenzyme profiles on either resident or thioglycollate (TG)
elicited macrophages.

Two hybridomas (T-3 and T-9) were selected for

further evaluation because of their activity patterns. Supernatants from
T-3 and T-9 were compared with cloned Y -interferon (y -IFN) for
alteration of biological activities. Both T-3 and T-9 were able to protect
resident macrophage cells from Naegleria but had no protective effect on
TG-macrophages. T-9 supernatant had patterns of activity sim ilar to Y
IFN while T-3 patterns were different.

The addition of anti-Y-IFN

removed T-9 cytostatic activity while not affecting T-3 induced activity.
The LK inducing protection from the cytopathic effect of Naegleria

xi

lysate is not Y-IFN but another m olecular moiety. It was also shown that
Y -IFN does not protect T G-macrophages from the destructive effects of
adenylate cyclase produced by Bordetella pertussis.

We conclude that

activation of macrophages for the destruction of tumor cells and
activation for protection against amoeba and bacteria occur via different
biological pathways.

Furthermore, we have proposed an association

between the cell cycle and the responsiveness of resident and TG-elicited
macrophages to specific LK.

INTRODUCTION
When Metchnikoff first introduced the term "macrophage" in 1883 the
major function of these cells was considered to be the rapid phagocytosis of
foreign particles.

Now over a century later, the role of the mononuclear

phagocyte in host defense has been found to be far more complex, playing an
important role in resistance to attack by parasites, tumors, and m icroorganisms
(31,47,52, 7 5).
The major e mphasis of this work is directed toward macrophage effector
functions against m icrobial infection and neoplastic cells. While the activation
of macrophage for these two mechanis ms occurs through similar stages, the
inducing

signals

appear

to

be

different

macrophage populations appear to exhibit

(31,21,1 1 3,114).

Furthermore,

variable degrees of efficiency in

performing these functions (1 1 3).
The macrophage has also been implicated in a variety of other functions
both i m munological and nonimmunological.

Their secretory function has been

well documented (91). The macrophage is also of considerable importance
because of its role in the regulation of the immune response (97,98,1 26) and may
also play a role in vascularization and wound healing (97, 1 1 3).
The diversity of macrophage function has lead to attempts to describe
discrete stages of activation, generally defined by the degree of microbicidal or
tumoricidal activity.

These stages have been characterized as resident,

inflam matory (responsive, primed), or activated.

Normal, unstimulated

peritoneal macrophages, are considered resident macrophages.

Macrophages

elicited by i.p. injection of a sterile agent such as thioglycollate, casein, or
protease-peptone

are

infla m matory

macrophages.

These

infla mmatory

macrophages are functionally "responsive" to LK(s). After LK treatment these
cells are prepared to become tu moricidal or m icrobicidal and are considered
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primed.

Exposure of these primed macrophages to a second signal such as

endotoxin or LK produces a fully activated macrophage.

Injection of Calmette

Guerin bacillus (BeG) or £. parvum (f. acnes) also results in the elicitation of
peritoneal macrophage which have tumoricidal activity.
M ononuclear phagocytes are an extre mely heterogeneous population of
They differ according to a number of biochemical and histochem ical

cells.

para meters and also differ markedly according to their tissue distribution (lungs,
liver, bone, spleen, connective tissue, serous cavities) (29,97). Even within one
location, macrophages vary in their morphology, state of differentiation, and
functional parameters (97,113).
There have been many attempts to explain the functional heterogeneity of
the

macrophage.

paems

(29) has suggested

that

while

infla mmatory

macrophages originate from bone-marrow-derived blood monocytes, the resident
macrophage is a self-renewing population.

This hypothesis is based upon

observations that resident macrophages regularly enter m itosis and give rise to
progeny of their own kind.

Van Furth (29) believes that all macrophages

originate from bone-marrow and that infla m matory stimuli and lymphocyte
derived biological modifiers, lymphokines ( LK), have a direct effect on the
macrophage and induce functional heterogeneity in a homogenous population of
bone marrow precursor cells. Bursuker and Goldmann (13) have proposed that a
heterogeneous population of bone marrow-derived macrophage-precursor cells
exists and that subsets of these precursors are differentially expanded under
normal and inflammatory conditions. A heterogeneous population of monocytes
then enters the circulation and under the influence of LK they migrate into local
tissues.

It is at this level where the tissue macrophage interacts with local

factors which determine the final functional state. A similar proposal suggests
that functional heterogeneity arises at the level of the monocyte and that
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monocyte·s give rise to separate lineages of macrophages which eventually result
in true macrophage populations that reside in specific tissues or organs

(11 2).

Both of these models result in terminally differentiated subpopulations in which
transition from one subpopulation to another would be severely restricted and
require retrodifferentiation to the level of a common precursor
Sorg and Newmann

(1 12) have

(1 12).

proposed a model in which macrophages pass

sequentially through a series of intermediate, stable phenotypes.
mechanism terminally

Under this

differentiated macrophages can rearrange their genetic

program and switch to phenotypes that can reenter into the cell cycle.

While it

is not clear which of these models is correct, the use of biochemical markers to

LK

define distinct stages of macrophage differentiation and purified
regulating

macrophage

homeostasis,

should

allow

for

the

as tools for

manipulation

of

macrophage effector functions and study of its regulation.
Origins of Mononuclear Phagocytes
The mononuclear phagocytes are of bone marrow (BM) origin arising from a
pluripotential s tem cell common to all hematopoietic cells
cell becomes committed, it gives rise to the monoblast.
has a cell cycle time of

(29).

The resulting

12

(29).

As this stem

The murine monoblast

hours and divides to give rise to two promonocytes

promonocytes have a cell cycle of

16

hours. These cells give

rise to the monocytes which leave the BM into the peripheral blood after
hours

and d o not

approximately

48

normally undergo

any

further

cell division

Monoblasts are difficult

(82)

to

identify

by

current

(29,97,1 34).

techniques;

is

however,

reported that they contain no granules and others report that

they lack any functional activity usually as sociated with monocytes
promonocyte

After

hr mature monocytes will randomly emigrate from the blood

into various tis sues and serous cavities and become macrophages

Nichols et a1.

(29).

24

a

large

cell,

(1 0-15

\lm

in

length)

with

(123).
a

The
large
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nuclear/cytoplasmic ratio, and prominent nucleoli. The azurophil granules are
i m mature and are peroxidase positive as are the cisternae of the rough
endoplasmic reticulum (RER) and the Golgi complex (83). It also contains the
lysozomal enzymes arylsulfatase and acid phosphatase (82). In the bone marrow
monocyte, the RER and the Golgi complex are peroxidase n egative and there is
the appearance of a second peroxidase negative granule.

No arylsulfatase

reactivity is present and acid phosphatase activity is greatly reduced.

The

nucleus is large with a horseshoe shape and the nuclear/cytoplasmic ratio is
decreased in comparison to the promonocyte (83). The mature blood monocyte
continues to form peroxidase negative granules and exhibit cellular membrane
ruffling (83).
Distinct

morphological

and

biochemical

changes

development of monoblasts into mature monocytes (6).
associated with the acquisition of functional character.

accompany

the

These changes are
As promonocytes

develop into blood monocytes and ultimately into tissue macrophages there is a
progressive

increase

in the number

of receptors for the

Fc

portion of

i m m unoglobulins and the C3b components of complement (6,134). There is also
an increased capacity for pinocytosis and phagocytosis (6)
number of the cells become esterase positive.

and an increasing

The development of these five

markers occurs in the majority of bone marrow derived mononuclear phagocytes
and are the basis by which they are identified (6).

In addition to these general

features of the mononuclear phagocytes, there are many biochemical properties
and functions acquired in response to inflam mation that distinguish the resident
tissue macrophage from the inflam matory macrophage.
Normally, as mononuclear phagocytes leave the BM they are fairly well
developed, express high levels of Ia antigen, and functionally responsive to
lymphokine.

As they m igrate into the tissues they appear

to become down-
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regulated or suppressed (l05). It is possible that in the absence of activating
stimuli,

the

macrophage

autoregulates

its

own

suppression.

Resident

macrophages, which are functionally at rest, produce sUbstantial amounts of
prostaglandin E (predom inantly PGE 2 ) which inhibits macrophage proliferation
and clonal expansion (6). It is particularly interesting that when promonocytes or
monocytes are re moved from the bone marrow (BM) and cultured in vitro, they
develop phenotypic and functional characteristics which resemble resident tissue
macrophages (6).
Receptors and Surface Antigens
Macrophages are known to bear over 30 distinct receptors (5). Changes in
the receptors being expressed can be used to characterize their state of
differentia tion.
As previously mentioned, the macrophage
with phagocytosis:

expresses receptors involved

i.e. the Fc receptors, receptors for comple ment, and a

receptor for mannose/fructose/N-acetylglucosamine terminated glycoproteins
(56,97). Peritoneal macrophages
recognizes

express two major Fc receptors.

FcRI

Y 2a while FcRII recognizes the y1 and Y 2b IgG isotypes (5,127).

The binding of these receptors reportedly results in the enhance ment of
phospholipase A2 , the arachidonic acid cascade and increased intracellular levels
of cyclic AMP (5). The number of FcRI and FcRII copies has been shown to vary
according to the maturational stage and this variation can be induced by
exposure to t3 or Y -interferon (13 0).

The number of FcRI and FcRII receptors

are higher in inflammatory than in resident peritoneal macrophages
Immunologically

mediated

inflam mation

(BCG-elicited

macrophage)

(5).
yields

macrophages with increased FcRI but decreased FcRII receptors (5, 27).
Macrophages in all stages of differentiation have been shown to express
receptors for complement components. The two major receptors, CR1 and CR3,
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recognize and bind different portions of the third component of comple ment (C3)
(5). It appears that C R1 and CR3 are functionally altered during development.
Resident macrophages bind but can not ingest complement�oated RBC's, while
inflam ma tory macrophages will bind and phagocytize antigen by these receptors
(5).

Griffin (34) has shown that in resident macrophages complement receptors

are not freely mobile in the phospholipid bilayer of the plasma me mbrane and
therefore do not gather around a bound particle to permit endocytosis.

In

infla m ma tory macrophages this is not the case as comple ment receptors are
fully mobile (5,34).
Peritoneal m acrophages

also have receptors for glycoproteins ending in

mannose, fucose, or N-ecetylglucosamine residues (4 5,1 1 8).
probably

aids in

m icroorganisms.

the
As

This receptor

recognition and phagocytosis of bacteria and other
is the case with comple ment receptors,

macrophage

activation leads to a decrease in the nu mber of these receptors (27).
Expression of class II major histocompatibility antigens (la antigens) are
important in antigen presentation by macrophage

to lymphocytes.

and Shevach (98) first noted that the macrophage

Rosenthal

and T cells must be

histocompatible in order to cooperate together in the im mune response. Only Ia
positive macrophages can function as accessory cells for the presentation of
antigen and re moval of these cells eliminates the immune response (139). The
presence of Ia antigens is characteristic of the activated macrophage. Resident
and inflam matory macrophages show low levels of Ia antigen; however, immune
e licited macrophages contain a large percentage of Ia�ositive cells (1 25,1 26).
The expression of Ia is induced in vitro by lymphokines ( M AP or Y-IFN), while it
is down regulated by prostaglandin E 2 (PGE 2 ) (5).
Recently, Ham ilton et al. (37) has correlated the expression of receptors
for the iron-binding glycoprotein, transferrin with macrophage

differentiation.
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Inflammatory macrophages

and monocytes express large numbers of receptors

for this molecule, while resident macrophages and i m mune-t!licited macrophages
express significantly fewer receptors (37). Interestingly, the transferrin receptor
is down regulated by the addition of macrophage activating factor (MAF) or
recombinant

y-IFN (37) and is therefore a use ful marker for examining the

mechanis m of action of these LKls on macrophages.
Many

investigators

have

ectoenzymes with macrophage

associated

the

expression

of

membrane

development, the most well characterized of

which is the 51nucleotidase (51N).

This enzyme hydrolyzes the phospho ester

linkage in 51-mononucleotides, liberating a nucleotide and inorganic phosphate
(23).

Resident peritoneal cells have been shown to contain high levels of this

enzyme.

In contrast, macrophages elicited by sterile or immune inflammatory

reagents exhibit dramatically reduced levels (22). This decrease has been shown
to result from increased me mbrane recycling and decreased synthesis of the
enzyme (5).

Because of the inverse relationship between expression of 5'N and

the inducibility of Ia antigen by M AF, this activity is thought to be regulated by
a signal(s) which leads to increased responsiveness to MAF (5) or perhaps
macrophages with low 51N express receptors for y -IFN.
The ectoenzymes, alkaline phosphodiesterase I (APD-I) and leucine amino
peptidase (LAP), have also been used to phenotypically characterize macrophage
populations.

A PD-I functions to sequentially re move terminal monophosphate

nucleotides from the 51 end of polyribonucleotides or oligodeoxyribonucleotides
starting at a nucleotide with a free 31-OH

group at the tail of the chain (24).

Leucine a minopeptidase sequentially cleaves amin o acids from the N-terminal
end of peptides in a nonspecific manner (71).

Both of these enzymes have been

found to increase several fold in inflammatory macrophages
resident

macrophages.

In activated

macrophage,

as compared to

LAP levels remain high;
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however, the level of APD-I appears to be even lower than that seen in resident
macrophages (2 2).
Peritoneal macrophages express receptors for regulatory molecules which
may act to induce or suppress macrophage

functions.

Many of these receptors

are constitutively expressed and are not altered as the macrophage proceeds
through the various stages of activation. The receptor for acetylated proteins
and lipoproteins are of this type.

The triggering of this receptor stimUlates

secretions of neutral proteases and in primed macrophages results in secretion
of plasminogen activator and cytolytic prote inase (5).

The receptors for Cl 2

macroglobulin are also present throughout the development o f tumoricidal and
m icrobicidal functions.

Binding of this receptor inhibits neutral protease

secretion and therefore acts in conjunction with the receptor for acetylated
proteins and lipoproteins to autoregulate the secretion of plasminogen activator
and cytolytic proteinase (5).
The receptor for colony-stimulating factor (eSF) is expressed early on in
development and all macrophage

populations respond to it, although the

magnitude of proliferation may vary.
greatest

proliferation

macrophages
engage ment
macrophages

in response

Infla m matory macrophages

to

esp,

while

show the

resident and activated

are much less responsive (5). In addition to cellular proliferation,
of

this

and

receptor

results

differentiation

of

in

increased

pre-monocytes

spreading
and

in

mature

monocytes

into

macrophages (130).
Many receptors for LK are expressed only as a result of humoral signals
received earlier in differentiation.

Identifying these receptors has proven

difficult until recently due to the lack of purified factors.

The migration

inhibitory factor (MIF) receptor has been identified as a L-fucose containing
glycoprotein (41). Receptors for macrophage activating factor (MAP) have been

9

much more difficult to define because

this molecule has been identified

functionally in Con A stimulated lymphocyte supernatants.

It is now thought

that activity once attributed to this one factor may indeed be do to several
lymphokines (30,3 1).

Gamma interferon is believed to be one form of M AP (5)

and receptors appear to be present in inflammatory (TG�licited) macrophages
but lacking in resident macrophages (37).

The binding of Y -IFN to its receptor

leads to increased cytolytic activity (89,95).
Peritoneal macrophages

express many other receptors too nu merous to

mention in detail. Some of these include receptors for lactoferrin, che motactic
factors, fibronectin, high density lipoproteins, fibrinogen, and insulin (5,97).
Secretory Functions
If any one characteristic could possibly begin to explain the diverse

functions of the macrophage perhaps it is the secretory function.
macrophage

The

is able to manufacture, secrete, and/or store a vast array o f

biologically active products, which include hydrolytic enzymes, cell stimulatory
proteins and a vast array of other molecules. On exposure to a variety of
inflammatory-inducing substances the macrophage

is triggered to release a

variety of acid hydrolases (cathepsins, hyaluronidase, B �lucuronidase, acid
phosphatase, aryl sulfatase) (5). These preformed enzymes are released within 46 hours from lysozomes (97) and release has been shown to be specific for
potentially

pathogenic

substances

since

the

phagocytosis

of

biologically

unreactive substances does not induce their release (91). Although their exact
extracellular function is not known these enzymes are believed to participate in
the initiation and perturbation of tissue destruction seen in chronic inflammatory
diseases (91,97).
Another major secretory product of the macrophage is lysozy me, a 14,000
molecular weight protein which hydrolyzes N-acetylmuramic-6 -1,4-N-acetyl-
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glucosam ine linkages of peptidoglycans in bacterial cell walls (5,91, 97).

Unlike

the acid hydrolases, lysozyme is a constituitive product of the macrophage
(91,97) and is secreted in large quantities by all macrophage populations (5).

A third group of hydrolytic enzymes produced by the macrophage are the
neutral proteases.

This group includes the enzymes elastase, collagenase,

plasminogen activator, and a cytolytic proteinase (91,97).

Unlike the acid

hydrolases, these enzymes are synthesized following a stimulatory event and
their production can be blocked by protein synthesis inhibitors (91,97).
While resident macrophages

secrete low levels of neutral proteases,

infla m matory macrophages secrete SUbstantial amounts. Werb and Gordon (1 3 3)
have reported that TG-elicited macrophages secrete high levels of collagenase
while resident

macrophages

produce barely detectable a mounts.

Resident

macrophages however, can be triggered to secrete slightly higher levels by
phagocytic stimuli.

These findings appear to be true for elastase, plasminogen

activator, and cytolytic proteinase enzymes as well (5,91,97).
The macrophage also secretes a variety of reactive oxygen intermediates.
These

include superoxide

anion,

hydrogen peroxide, and hydroxyl radical

(5,6,50,78,97). Evidence suggests that these oxygen metabolites play a role in the
tumoricidal and microbicidal functions of the macrophage .

Murray et al. (75)

has shown that these highly reactive molecules are involved in killing of the
intracellular parasite Toxoplasma gondii.
release of H 2 0 2 by activated macrophages

Others have demonstrated that the
leads to the rapid lysis of certain

tumor cell targets (78,79,80,81). Inflammatory macrophages have been shown to
have a 1 0-fold greater secretory capacity
than resident macrophages (10 0).
activated !!! vivo by BGG or f.
oxygen intermediates (6).

of reactive oxygen

However, macrophages

intermediates

immunologically

acnes secrete the largest amounts of these
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Macrophages serve as a major source of arachidonic acid metabolites such
as prostaglandins of the E series, leukotriene C 4 and B4 , and thromboxane B 2
(5,92,97,10 7).

Prostaglandin E 1 , is known to greatly enhance collagenase

production in stimulated macrophages.

They have also been shown to exhibit

antiproliferative and i m munosuppressive effects (5,97) on T cells and to inhibit
generation of many lymphokines (68). Thromboxane B 2 is a principle metabolite
of the macrophage as a result of phagocytic stimuli (92) and is a potent mediator
of vasoconstriction and platelet aggregation (36). Two major leukotrienes are
also secreted.

Leukotriene C 4 (slow-reacting substance of anaphylaxis) and

leukotriene B4 , a potent chemotactic factor are generated by the lipooxygenase
pathway (97).
Macrophages produces a variety of compounds with stimulatory activity on
cells involved in immune regulation. Macrophages produce CSF sim ilar to that
produced by the fibroblast L92 9. This factor is produced by all macrophages and
acts to regulate macrophage morphology, differentiation, and proliferation (5).
Macrophages also secrete Class I (�) interferon.

Secretion of �-IFN has

been shown to be induced by CSF (1 30). It has been suggested that this e nables
the macrophage

to auto regulate its function by providing the signals necessary

for differentiation into a responsive macrophage (130). Warren and Vogel (130)
have recently shown �-IFN can increase Fc-mediated phagocytosis
presence of highly purified, �-IFN depleted CSF.

in the

This increased activity is

elim inated with the addition of anti-6 -IFN. Furthermore, �-IFN can provide the
appropriate signal necessary for activation for tu moricidal activity although it is
quantitatively less e ffective than Y-IFN (90).
Interleukin 1 (1L-1 ) or lymphocyte activating factor is a major signal for
lymphocyte stimUlation.

It is released by macrophages

in response to viral,

bacterial, and fungal infection (5). IL-1 appears to be identical to endogenous
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pyrogen which induces the febrile response

and regulates several phenomena

associated with infla m m ation (97,1 10).
Activated and inflam matory macrophages secrete components of both the
classical and alternative complement pathways. These include Clq, C2, C3, C4,
C5,

factor

B,

factor

D,

properdin,

C3b-inactivator,

and

BIH

(5,11,62).

Supernatants from antigen stimulated lymphocytes have been shown to enhance
production of these complement components (62).

Resident and inflammatory

macrophages secrete the largest quantities and produce the largest number of
individual products compared to activated macrophages (5).
have shown that the

Scott et al. (107)

overall secretory capacity of these products is down

regulated as a consequence of the activated state.
Macrophage Regulatory and Effector Functions
Macrophages exhibit three major functional roles in the i mmune response.
First, they act as scavengers of extracellular debris (5,97,1 34).

Second, they

play a regulatory role in the induction of the immune response, having been
shown to display both activational and suppressive controls (5,97,1 25).

Third,

macrophages serve as effector cells capable of destroying viruses (5), bacterial
(50),

intracellular and extracellular parasites (12,50,86), and tumor cells

(2,4,5,6,80).
The phagocytic role of the macrophage
(15,134).

has long since been established

Although earlier investigators had de monstrated the phagocytic

capability of the macrophage (15), Metchnikoff was the first to establish their
importance and de monstrated that animals resistant to certain bacterial
infections had an increased capacity for phagocytosis of m icroorganisms (5,15).
Virtually all macrophage

populations in various stages of differentiation

express some phagocytic ability (97). Cells from the promonocyte stage onward
have been demonstrated to phagocytose latex beads nonspecifically and IgG
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coated particles specifically by Fc receptors (5,97,1 3 0). Opsonized particles
coated with the C3 component of comple ment can also be ingested via a
comple ment receptor (25,34).
Phagocytosis can be divided into three stages:

attachment to the

macrophage, ingestion of the particle, and digestion within a phagolysosome
(15,1 34).

The initial attachment and recognition occurs by the receptors

previously mentioned.

Normally, complement and IgG coated particles are

phagocytized by a zipper-like mechanism in which F c and C3 receptors on the
surface of the macrophage direct move ment of the membrane over the surface
of the particle ( 1 3 4).

However, particle attachment does not always indicate

phagocytic recognition (93).

At low receptor densities

particles may bind

macrophage surface receptors without being ingested (93,1 3 4).

If receptors on

the macrophage surface are not mobile enought in the fluid phase of the
membrane to allow zippering then phagocytosis is also interrupted at binding
(5,134).
When zippering is triggered, the particle is surrounded by the macrophage
membrane.

Once this circumferential zippering is completed, an endocytic

vacuole known as a phagosome is formed. This phagosome fuses with a primary
or secondary lysosome to form a phagolysosome (1 34). Within this compartment,
the phagocytosed material is digested at low pH by a barrage of hydrolytic
enzymes (134).
Phagocytosis

is

greatly

enhanced

in

inflammatory

compared to resident peritoneal macrophages (5,1 1 2).

macrophages

as

This increased efficiency

is partly due to an increase in the number of FcRI and FcRII in inflammatory
macrophages (5).

In contrast, resident macrophages have higher numbers of

complement receptors but because they are not freely mobile in the membrane,
bound particles are not ingested (5,34). Infla m matory macrophages also have
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increased reserves of phosphocreatine which is a major energy source during
phagocytosis (5).
The positive immunogenic role of the macrophage is a result of two well
defined s teps.

First, they have been shown to remove extracellular debris

(antigen); and second, they can retain degraded pep tides (antigen) in lymphoid
tissue

for presentation

to immunospecific

lymphocytes.

Mosier (73)

first

demonstrated the requirement for adherent cells in the im mune response to
sheep red blood cells (SRBC).

He cultured murine spleen cells in plastic dishes

for 30 m in and removed the adherent cells.

Neither fraction (adherent or

nonadherent cells) could respond in vitro to SRBC.

However, when the fractions

were mixed together anti-SRBC antibodies were produced.

Nossal et al. (87)

were the first to show that in vivo, injected antigen localizes in the lymph node
medulla and persists for long periods of time within the macrophages.
A third step, which until recently was somewhat obscure, is the actual
presentation of antigen to the lymphocytes. In order for an accessory cell to
perform this function, it must be able to express Class II glycoproteins (Ia
antigens) on its surface, process antigen, and synthesize and release interleukin 1
(126).
The i mportance of Ia antigens was first described by Rosenthal and
Shevach

(109)

who demonstrated that macrophages and T cell

histocompatible in order to result in lymphocytic proliferation.

must

be

Using strain 2

and strain 13 guinea pigs, they found that antigen-pulsed macrophages

could

activate syngeneic lymphocytes while allogeneic macrophages failed to activate
T cell proliferation. Because the M HC's of strain

2 and strain 13 guinea pigs

differ only at the I-region, they proposed that identity between I-region antigens
is required for effective T-cell-macrophage interactions. In an accompanying
paper, (109) they showed that antigenic non-responders were a result of a
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macrophage defect in which antigen could not be presented to T lymphocytes in
an effective way.
Further studies have shown that it is the macrophage and not the T cell Ia
antigens that are important in these interactions.

Thomas and Shevach (120)

demonstrated that the receptor on the helper T cell recognizes antigen in
association with the H-21 region product and this product does not need to be
expressed by both the macrophage and the T cell. In addition, the killing of Ia
positive macrophage

with anti-Ia and complement was shown to impair the

immun e response to antigen (139) while re moval of Ia-positive T cells had no
effect (1 2 1).
Macrophages have been demonstrated to internalize antigenic proteins
where

they are catabolized to smaller fragments and later found either

associated with the cell surface or released into the culture supernatant (1 2 6).
Using lysosomotropic agents, such as chloroquine or a mmonium chloride, to raise
the pH of lysosomes results

in the inhibition of antigen-presenting functions.

This indicates the need for antigen to be internalized and processed in an acidic
vesicle before it can be expressed on the cell surface for presentation (126).
Unanue (126) has shown that untreated macrophages can present hen egg
lysozy me (HEL) to T cell hybridoms, paraformaldehyde-fixed cells could not.
However, trypsin treated HEL

could be presented by live macrophages

or

prefixed macrophages. Amino acid analysis of the im munogenic peptide revealed
a very nonpolar portion and an area of predominantly polar amino acids.
It has been suggested that globular proteins or proteins of microbial origin
must go through a processing stage in order to be expressed on the macrophage
surface m embrane.

The fragment expressed must contain an immunogenic

determinant, distinct from those of self-proteins, in association with a nonpolar
stretch of a mino acids for anchorage in the membrane (126). These immunogenic
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fragments then either complex directly with Ia molecules or are located in close
proximity with Ia due to random collisions in the membrane (126).
When a T helper cell precursor recognizes antigen in association

with Ia

antigens, the macrophage is stimulated to secrete IL-l. IL-1 in turn, serves as a
stimulus for T cell activation which signals T helper cell precursors to
differentiate into helper effector cells.

These cells express receptors for and

secrete IL-2 (T cell growth factor) (42).
Several investigators have demonstrated the need for 1L-1 for efficient
antigen presentation.

Kramer and Unanue (58) indicated that while B cells are

1 0-10 0 times less effective at presenting KLH, the addition of macrophage
conditioned media was able to increase their accessory function.

Scala and

Oppenheim (101) showed that monocytes pulsed with antigen and treated with
paraformaldehyde could only present antigen to T lymphocytes in the presence of
IL-l.

M onocytes fixed prior to the antigen pulse could not present antigen even

when IL-1 was added to the culture.
Thus the macrophage appears to be perfectly suited for its accessory role

in antigen presentation. It is capable of interacting with a variety of antigenic
proteins, processing them for expression on the cell membrane in association
with Ia antigens, and secretes IL-l.

While the role of other Ia positive cells in

antigen presentation is unclear, the macrophage

appears to be of major

importance.
In addition to its immunostimulatory role, the macrophage
vital role in suppression of the i m mune response.

also plays a

Macrophages !!! vitro have

been shown to inhibit lymphocyte functions, particularly at high nu mbers or if
activated for tumoricidal or m icrobicidal functions (125).
role of the activated macrophage

It is this suppressive

that may prevent immune responses from

becoming exceedingly destructive (97).
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The suppressive effects of the macrophage

are best realized

by the

secretion of prostaglandins, thymidine, oxygen intermediated and other factors
(97,1 25). Prostaglandins have been shown in vivo to decrease antibody formation
and in vitro to lower antigen and m itogen induced lymphocyte stimulation (97).
Cyclooxygenase inhibitors such as indomethacin have been shown to reverse the
inhibitory effects of macrophages in macrophage -lymphocyte interactions (1 25);
however, it reportedly has no effect on macrophage

tumoricidal activity ( 1 1 1).

Thymidine appears to be a potent inhibitor of the i m mune response by interfering
with the conversion of cytidylate to deoxycytidylate and blocking DNA synthesis
( 1 16).

High levels of thymidine have been shown to inhibit the proliferation of

rapidly dividing lymphocytes and thymocytes ( 1 17).
Macrophages have· also been found to secrete large quantities of the
enzyme arginase which

catabolize the essential amino acid arginine and

reportedly suppresses lymphocyte proliferation (1 8,59,97).

Oxygen m etabolites,

particularly hydrogen peroxide may also inhibit lymphocyte proliferation in
response to antigen (69).

Given that the addition of reducing agents such as 2 -

mercaptoethanol enhances the proliferative response o f lymphocytes t o antigen
( 1 2 5), a proposed immunosuppressive role for oxygen intermediates is not
unfounded.
The term "activated" in reference to large, nonspecifically microbicidal
macrophages

was

first

introduced by

Mackaness (63).

Later,

when

the

tumoricidal activity of these macrophages was realized (40) the definition was
expanded.
Development of the activated macrophage appears to be a complex,
multistep process. As monocytes leave the circulation and enter into the tissues,
the macrophage becomes exposed to a variety of positive and negative effector
molecules that induce morphological,

metabolic, and physiological changes

18

activating them for a variety of functions (5). It should be strongly emphasized
that macrophage
synonymous

activation for destruction of tumor cells is not always

with

(30,3 1,51,52,135).

activation

for

the

Because

this

term

investigators should

take

care

destruction
has

been

of

microorganisms

operationally

to indicate the function

for

defined,

which the

macrophage has been activated.
It is now well established

that the macrophage plays a central role in

protection against facultative and obligate bacterial pathogens (51,63,108).
Activated macrophages

are also important in the elimination of viruses and

extracellular parasites and protozoans (30,56,85,1 36).
Metchnikoff first noted that macrophages

from i m mune animals showed

increased resistance to bacterial challenge due to their increased phagocytosis
and microbicidal activity (5).

It was later determined that macrophages

responding to infection with one organism could nonspecifically resist infection
against antigenically unrelated bacteria (9). Fowles et al. (28) demonstrated the
link between specific cell-mediated i mmunity and the nonspeCific functions of
the activated macrophage

when they demonstrated that culture supernatants

from antigen specific T lym phocytes could activate macrophages for nonspecific
protective functions.
The mechanism by which macrophages

recognize such a wide range of

microorganisms is not well known; however, the ability to distinguish and respond
to unrelated

microorganisms has been demonstrated to occur by several

mechanisms.

Multicellular parasites (e.g. Schistosoma, Trichinella) are killed

extracellularly by an IgE-dependent

mechanism (26,2 0). Capron et al. (14)

demonstrated that serum IgE acted on the macrophage because preincubation of
schistosomula

with

immun e

serum

did

not

induce

killing

while

treated
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macrophages were activated within one hour.
Fc-mediated phagocytosis is probably the primary i m mune-mediated mechanism
for m icrobial attachment to macrophages.

The protozon parasite Toxoplasma

gondii is bound to the macrophage plasma m embrane via the FcU receptors when
opsonized with serum IgG (74).
particularly

important

with

Phagocytosis directed by these receptors is

encapsulated

bacteria

such

as

Steptococcus

pneumoniae, Hemophilus influenzae, and Neisseria meningitidis (74).
Comple ment receptors (CR l , CR3) also play a role in the uptake of
microorganisms and is believed to play an i mportant role when a nonimmune host
is first confronted with an organism.

Lipopolysaccharide from bacterial cell

walls has been shown to bind complement thereby promoting the uptake of the
organism (74). Nonimmune receptors may also play a role in the binding and
uptake of some m icrobes.

These receptors have been suggested to play

an

important role in the defense against microorganisms which fail to stimulate a
strong humoral response and in nonimmune animals (74). Receptors recognizing
glycoproteins ending in mannose or frucose have been reported to play a role in
the

phagocytosis

of

Salmonella

typhimurium,

Klebsiella

aerogenes,

and

Corynebacterium parvum (132).
Attempts to demonstrate activation of macrophages

for microbicidal

activity in vitro were initially futile due to the extracellular replication of
target m icrobes (77).

The replacement of facultative intracellular bacteria by

obligate intracellular parasites avoids this problem and allows an accurate
assessment

of

the

role

macrophage

in

protection

against

pathogenic

microorganisms.
In nonimmune macrophages, Toxoplasma,

Leishmania, and Trypanosoma

�. enter by endocytosis but then reside in different locations within the cell.
The uptake of these protozoans fails to trigger an oxidative respiratory burst or
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synthesis of lysosomal enzymes.

Toxoplasma gondii has been demonstrated to

prevent fusion of the phagosome with lysosomes by altering the phagosomal
membrane by an unknown m echanism.

Leshmania amastigotes replicate within

the phagolysosome by inactivating lysosomal enzymes and Trypanosoma cruzi
lyse the phagosomal membrane and replicate in the cytosol (52).
When exposed to antigen and ConA"",timulated splenic supernatants,
m icrobicidal
macrophages

activity

can be

(52,85).

induced in both resident and inflammatory

This

acquisition

of

microbicidal

activity

against

Leshmania, Toxoplasma, Trypanosomes, and Candida has been demonstrated to
be closely linked with increased production of H2 0 2 and other reactive oxygen
intermediates (52,74,75,76,85).
Murray et al. (75) has reported the augmented oxidative capacity of I.
to be antigen speCific since boosting T. gondii

gondii activated macrophages

immune mice (i.p.) with the same organism resulted in increased H 2 0 2 and
superoxide anion (0 2 -) generation.

Boosting with BCG or PPD (purified protein

derivative) did not increase these oxygen intermediates.

These differences are

thought to result from increased lymphokine production in antigen"",timulated T
cells (76).
Microbicidal activity may possibly be enhanced by other nonoxidative
mechanisms; however, their importance here remains to be established. Some of
these mechanisms include lowering the pH of the phagosomes, secretion of
lysozymal hydrolases, and the production of cationic proteins and peptides (5,60).
The macrophage

has also been found to play an important role in the

destruction of neoplastic cells.

Alexander and Evans (7) first reported that

exposure of peritoneal macrophage

to LPS or double standard RNA rendered

them cytotoxic to both syngeneic and allogeneic lymphoma cells.

Hibbs et al.

(38,39) found that macrophages activated for microbicidal functions using agents
such as BCG, .£. parvum, !!.

pertussis, and I. gondii were also cytotoxic to
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tumor cells but not to normal untransformed cells. Consequently, because these
macrophages

were obtained from mice responding to microbial infections,

tumoricidal macrophages were considered to be "activated" by definition.
Macrophage-mediated tumor cell cytotoxicity is a multistep process which
involves: specific binding of neoplastic target cells; prolonged contact with the
tumor cell target; and secretion of

lytic products which appear to alter the

integrity of the target m embrane (5). Resident and thioglycollate-elicited
macrophages

have been shown to interact very little with adherent or

nonadherent tumor cell targets in vitro.

In contrast, macrophages activated by

macrophage activating factor ( M AF) and LPS have been shown to come into
intimate contact with tumor cell targets (5,6).

Using electron m icroscopy,

activated macrophages can be observed to spread out over their target in
clusters with their cytoplasmic m embranes closely molded to it for several hours
(6).

After 6 hr of contact with activated macrophages, tumor cell division is

almost completely abrogated (6). This cytostatic activity is followed by swelling
of the cytoplasmic membrane (6) and complete lysis of the neoplastic cell within
1 6-18 hours (4).
The activated macrophage appears to be highly efficient and selective in
destruction of neoplastic cells in vitro.

One macrophage appears capable of

lysing several targets; and when added to mixed cultures of neoplastic and
nonneoplastic cells, they are not cytolytic for the normal cells (6).
Specific binding of tumor cell targets can be augmented by the treatment
of inflam matory, but not resident, macrophages with LK (6,65). Binding capacity
appears to be maximal after 8-12 hours of LK treatment (48). Augmented binding
requires metabolically active macrophages; however, dead targets are bound (6).
Intact microtubules and microfilaments are also necessary as demonstrated by
the inhibition of tumor cell binding by the colchicine treatment (48). Specific
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binding has also been shown to require the presenae of a trypsin sensitive
membrane structure and the presence of divalent aations (6).

Examination of

tumor cell binding by m acrophages using electron microscopy reveals a small
It has been proposed that this

space or cleft between the points of contact.

space functions to concentrate and protect lytic mediators (5,6,48).
While the activated macrophage has been reported to secrete many factors
cytotoxic to other cells (4), few have been well characterized.

The most

extensively studied of these factors involved with macrophage-mediated tumor
aytolysis includes arginase, hydrogen peroxide, and a novel cytolytic protease.
Neoplastic cells have been demonstrated to require large a mounts of
arginine and because m acrophages are known to secrete high concentrations of
arginase it has been considered a possible mediator of macrophage-mediated
tumor cytotoxicity.

The major support for arginase in this role is the finding

that

block

arginine

can

cytotoxicity assays (4).

tumor

cytolysis

when

included

in

macrophage

Arginase probably does not play a m ajor role because it

is seareted by inflam m atory as well as aativated macrophages and therefore does
not correlate with tumor cell cytotoxicity (4,5,6).
Hydrogen peroxide has been implicated in m icrobicidal function of the
macrophage and m ay also play a role in tumoricidal aativities.

It has been

reported to lyse a variety of tumor cells; however, the effective concentration
varies widely (79,80). Inhibition of H 2 0 2 activity by catalase and anaerobiosis do
not inhibit macrophage-mediated cytolysis.

Therefore, while H 2 0 2 may play a

role in tumor destruction, apparently it is not a sufficient mediator on its own.
Adams et al. (1) first reported the presence of a novel serine protease
present in the

supernatants of BCG-activated macrophages but not in the

supernatants from resident and inflammatory macrophages.

This cytolytic

protease (CP) is quite potent, having a 50% cytolytic concentration of around 1.0
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x l O-9 M (4). Much evidence has accumulated indicating the importance of C P in
macrophage-mediated lysis of neoplastic cells.

First,

there

is a strong

correlation between the secretion of CP and the development and expression of
tumoricidal activity.

Resident and inflammatory macrophages do not display

tumoricidal activity nor do they secrete CPo Immune-elicited (BCG, �. �)
or inflam matory macrophage treated with LK and LPS in vitro are cytolytic and
secrete

CP spontaneously (4,48).

Second, low molecular weight protease

inhibitors block CP activity and inhibit tumoricidal activity of

activated

macrophage and do so by acting at the target injury stage (47). Third, binding of
viable tumor cells or plasma m embranes by BCG-elicited macrophage results in
secretion of CP while normal cells do not trigger CP release (4). Furthermore,
addition of tumor cells to inflammatory macrophage does not stimulate CP
release (48). Finally, the kinetics for the destruction of n eoplastic cells in vitro
with CP is similar to that of macrophage-mediated tumor cell cytotoxicity (4,6).
Taken

together, these findings indicate that

CP is a major effector of

macrophage-mediated tumor cytotoxicity.
Adams et al. (2) have shown that while H 2 0 2 is unable to mediate tumor
cytolysis, it appears to act synergistically with CPo
non-lytic

concentrations

of

H2 0 2

( lO -6 M

or

Exposure of tumor cells to

less)

concentrations of CP results in target cell lysis.

along

with

non-lytic

It is possible that other

secretory products of activated macrophages may act in conjunction with each
other in a similar manner to mediate tumor cell killing.
Another lytic m echanism for the destruction of tumor cells by activated
macrophages

involves

antibody-dependent

Antibody-<lependent cellular cytotoxicity

cellular

cytotoxicity

(ADCC).

appears to be a multistep event

similar to direct tumor cytotoxicity, requiring binding of tumor targets and
release of cytolytic mediators.

However, the m ethod of target recognition and
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lysis i s different. This m echanism kills neoplastic cells indirectly by recognition
of the Fc portion of i m munoglobulin (IgG) specific for determinants of the target
cell (3).

Direct contact-mediated cytolysis can require 1-3 days, in contrast,

ADCC can result in tumor cell lysis within 4-6 hours (3,6).
Other findings have indicated that activation of macrophages for direct
tumor cytolysis is distinct from activation for A DCC.

Peritoneal macrophages

elicited by BCG in C 3 H/HeJ and A/J mice, which are genetically deficient for
the ability to recognize and lyse neoplastic cells respectively, can be activated
for A DCC (3).

This suggests that these two mechanisms differ in both the

recognition and effector steps (3).
Nathan and Cohn (81) have suggested that H 2 0 2 may be the lytic mediator
of ADCC.

It has been shown that anaerobiosis, deprivation of glucose, or

addition of H 2 0 2 scavengers such as thioglycollate inhibit ADCC activity (4).
Binding of macrophage Fc receptors has also been shown to trigger the release of
large quantities of H 2 0 2 (4,5).

These findings seem to indicate a major role for

oxygen m etabolites in A DCC.
A third function mediated by macrophages against neoplastic cells is target
cytostasis.

When tumor cells are cocultured in the presence of activated

macrophages they show a reduced rate of cell division (6,3 0). This cytostatic
activity can result by blocking DNA synthesis (8 phase) or mitosis in the target
cell (5, 6).
K eller (54) demonstrated that whether an activated macrophage will be
tumoricidal or cytostatic is dependent upon the tumor target, as certain tumor
cells which are more resistant to cytolysis may still be vulnerable to the
cytostatic mechanism of the activated macrophage. The inhibition of division in
neoplastic cells can occur as a result of a reversible process or an irreversible
process which leads to destruction of the cell. The mouse adenosarcoma cell line
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EMT-6

shows a reduction in cell division

in the presence of activated

macrophages. This effect is reversible upon removal of the effector cells from
culture (5,6).

Cytostasis is also m anifested in target cells before they are lysed

by activated macrophages (6). Although the results are sim ilar, the mechanism
from which these two events arise are quite different.
The mechanism by which activated macrophages mediate their cytostatic
effect is not well known.

Of the possible cytotoxic substances secreted by the

activated macrophage thymidine, arginase, prostaglandin (PGE), and interferon
have all demonstrated anti-proliferative e ffects on neoplastic cells in vitro
(6,35,97).
Signal Requirements for Macrophage Activation
A ctivation of inflammatory or responsive

macrophages for cytotoxic

activity directed towards tumor cell or microbial targets requires a two stage
reaction sequence:

a priming signal which induces a responsive, noncytotoxic

state, a.nd a triggering signal which stimulates the macrophage to become
functionally activated (77).

Resident macrophages which are unresponsive to

activating signals become responsive when cultured for several days (6).
The priming signal for responsive macrophages has been demonstrated in
vitro to be supplied by T cell-derived LK(s) known functionally as macrophage
activating factor (MAF) (6,8). The primed macrophages can then be activated by
nanogram

quantities

of endotoxin.

Other

products

such as

tumor

cell

supernatant, a low molecular weight serum factor, maleylated protein, and high
doses of LK can also provide the triggering signal (6).
While there are obvious similarities in the regulation of tumoricidal and
microbicidal functions, they may be dissociated according to the regulating
signals required.

T cell LK's appear to have an omnipotent role in functional

regulation and activation of macrophages (31,89,1 1 4 , 1 38). It has been shown tha.t

T cells can produce a variety of LK's

with distinct physiological influences on

the macrophage (31). Macrophages have also been shown to be heterogeneous in
their response to the various L K's

( 1 1 4).

Therefore, the use of crude

supernatants from mitogen- and antigen-,stimulated lymphocytes is of li mited
value in determining the signals and events leading to functional activation.
Determining the relationship between soluble T cell mediators and the
regulation of macrophage functions m ust be approached at a single cell level;
however, obtaining enough m aterial from a single T-lymphocyte is impossible.
' When Kohler and Milstein (57) announced that they had im mortalized an antigen
specific, IgG secreting plasmacytoma (P3-X63Ag8) with spleen cells from
i m m unized mice, they opened the door for more in-depth stUdies concerning the
precise nature of T cell-macrophage interactions.
The

techniques

for

preparing

T

cell

hybridomas

is

essentially

a

modification of the Kohler-M ilstein m ethod for the production of monoclonal
antibody secreting cell lines but in which helper or suppressor T cells are fused
with B W 5 1 47, a Thy 1 . 1 positive cell line of A K R (H-2 k ) origin. Hybrid cells are
then cultured in selective HAT medium (DMEM, 10% FeS, 1 0 0 llm hypoxanthine,
10 llM a minopterin, 30 llM thymidine). The BW5147 is deficient in the enzyme
hypoxanthine guanine phosphoribosyl transferase (HGPRT) and cannot survive for
longer than 24-48 hours in this medium (57).

All cells living at day 1 4 can be

assumed successful fusions since survival requires the HGPRT gene from the
spleen cell parent and the genetic information for continuous growth from the
lymphom a parent (99).

Once the hybridomas become established they can be

screened for the production of the desired lymphokines. Hybridoma technology
offers a straightforward approach for determining the number and nature of the
LK's produced by different T cell subsets.

T cell hybridomas are a great

advantage as they provide a defined source of material for functional,
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biochemical and genetic analysis.
Hypothesis
It has been proposed that macrophages in various states of functional
activation (i.e. resident, responsive, primed, and fully activated) are in different
stages of the cell cycle.

During these stages, the macrophages differ markedly

in their capacity to respond to LK ( 1 1 2 , 1 1 3,11 4). In order to look more precisely
into the process of macrophage activation and the role of T cell derived LK's we
have constructed T cell hybridomas. The purpose of this study was to determine
the role of T cell hybridoma LK's and recombinant Y -interferon in inducing
different protective mechanisms in various macrophage populations.

This was

done by challenging in vitro with tumor cells, live opportunistic amoebae and
a moebic or bacterial lysates. Supernatants from T cell hybridoma lines T-3 and
T-9 were both capable of protecting resident macrophages from Naegleria
lysates but are unable to elicit a similar response in TG macrophages.

Gamma

interferon treatment did not protect either macrophage population.

It was

further demonstrated that Y -interferon does not protect TG macrophages from
the destructive effects of the adenylate cyclase enzyme of Bordetella. We have,
therefore, concluded that protection from the cytopathic amoeba Naegleria
fowleri and the bacterium Bordetella pertussis is a non- y-interferon induced
mechanism distinct from the mechanism involved in the destruction of tumor
cells.
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M ATERIALS A N D M ETHODS
Animals.

Eight to ten week old, female C3H/HeN mice (Charles River

Breeding Laboratories, Kingston, NY) were used in this study as the source of
resident and thioglycollate (TG) macrophages.
Peritoneal macrophages. Resident and TG-macrophages were harvested by
reflecting the skin over the abdomen and injecting 5.0 mls of Hank's balanced
salt solution (HBSS); Ca ++/Mg++ free) into the peritoneal cavity. After agitating
the abdomen, cells were drawn off and suspended in HBSS.
centrifuged at 5 0 0 x g at 250C,

Cells were

washed twice, and resuspended in 1 0 ml of

Dulbecco's modified minimum essential medium (DMEM) (Flow Laboratories) +
10% FCS.

Red blood cells were lysed with 5.0 ml tris-buffered NH 4 CI (pH 7.2).

TG-macrophages were obtained from mice receiving 1.0 ml (i.p.) of 10% Brewer's
thioglycollate 4 days prior.
Tissue culture

media.

T-cell hybridomas were cultured in

DMEM

supplemented with 10% FCS, 2 mM glutamine, penicillin and streptomycin (100
�/mI), 4% sodium bicarbonate, and 1 5 m M HEPES (pH 7.2).
lines were also maintained in HBI0 l
culturing

serum-free

Hybridoma T-cell

medium specifically

for

murine

myeloma and hybridoma cell lines (Hana Biologics, Inc.,

Berkeley, Calif.).

Hybridomas were adapted and maintained in this medium to

facilitate the isolation and purification of T cell derived LK's.
T-cell hybridoma culture supernatants.
as described by Niederhuber et al. (84).

T-cell hybridomas were prepared

Briefly, l x l 0 7 HAT sensitive BW5147

thymic lymphosarcoma cells were fused with l x l 0 8 nylon wool purified, ConA
stimulated splenic T-cells (Fig. 1). Hybrid cells were recloned by limiting dilution
and screened for their ability to protect adherent resident peritoneal cells
against the effect of Naegleria cytotoxic factor(s), their ability to increase
tumor cell cytolysis by TG-elicited macrophages,

and induction of Ia antigen
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expression in TG-elicited macrophages after 2 4 hr of treatment.

When used for

lymphokine production, T cell hybridomas T-3 and T-9 were seeded at either
1x10 6 cells/ml in DMEM + 1 0% FCS or 6x10 4 cells/ml in HB101 serum free
media. Supernatants were collected after 24-48 hr by centrifugation at 500 x g
for 1 0 min at 4 o c.
Determination of hybridoma division time.

T-cell hybridomas were maintained

at 1x10 6 cells/ml in DMEM + 1 0% FCS.

Total cell number per flask was

determined at 24, 48, and 72 hr.
IL-2 assay.

IL-2 dependent, C10 cells ( l x10 4 cells) were cultured for 24 hour

along with serial dilutions of T-3 and T-9 supernatants in flat bottom tissue
culture plates.

C 1 0 were also cultured in TCGF conditioned medium or DMEM

as positive and negative controls. The cells were then pulsed with 1IJCi 3 H-TdR
for an additional 24 hour. Wells were harvested using a MASH cell harvester and
assayed using a liquid scintillation counter.
Induction of hybridoma derived LK. In an attempt to maximize the production of
L K from hybridomas T-3 and T-9, cells were incubated at various densities
(2.5x10 4 , 5x10 4 , 1x10 5 m 5x10 5) with or without 5IJg ConA. At 24 and 48 hr, 5.0
ml of supernatant was collected and the ConA was absorbed out of the
supernatants by adding G-25 sepharose beads and centrifuging at 1000 x G for 1 0
m in. Con A-free supernatants were then collected. The amount of LK produced
was reflected as the percent cytostasis induced by the supernatants in TG
macrophage (cytostasis assay was performed as described earlier).
Macrophage-mediated destruction of Naegleria fowleri.

Resident macrophages

(2 x 1 0 5 ) were incubated along with diluted T-3 or T-9 supernatants (1:1, 1 :2,
1 :8).

After 2 4 hrs, 2 x 10 4 3 H -uridine labelled !!. fowleri target cells (which

had been cultured with 51J Ci 3 H
additional

24

hr,

100

III

-uridine 2 4 hr prior) were added.
of

each

culture

After an

supernatant

was
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removed and added to 3 m l o f Beckman redi-solve scintillation fluid. All samples
were run in triplicate and assayed using a liquid scintillation counter (2 min, 2 %
error).
ASsay for macrophage protection against Naegleria fowleri lysate. Naegleria
lysates

were provided

by

Dr.

Francine

Marciano-Cabral (Department of

Microbiology and Immunology, Medical College of Virginia) and were prepared by
freeze-thawing using a dry ice - EtOH bath, followed by submersion in a hot
water bath for 30 sec.

After freeze-thawing 4 times, the amoebae were

sonicated for 3, one min intervals.

Resident and thioglycollate-recruited

macrophages were cultured at 3x10 5 , 1 .5x10 5 , and 3x10 4 cells/ml along with
3x10 4 equivalents of crude !i. fowleri lysate (lysate equal to 3x10 4 live
Naegleria), and either recombinant y -IFN, T-3, or T-9 at 370C and 5% C0 2 ' At
the end of 18 hr, the macrophages were pulsed for 2 hr with 50 \.11 (5 \.ICi) of Na 2
5 1 Cr0 ' The wells were washed 3 times to re move unbound 51 Cr and then 1 0 0 J.I1
4
of I N NaOH was added and incubated for 5 min at room temperature.

This was

repeated once again and then samples were radioassayed using a LKB ga mma
counter (all samples were run in triplicate).
Assay for macrophage protection against Bordetella pertussis lysates. Resident
and TG-macrophages were cultured at 3x10 5 , 1 .5x1 0 5 , and 3x10 4 cells/ml along
with lysates from Bordetella strain BP338 (wild type) (45 J.Ig protein/ml) and
recombinant y -IFN. After 18 hr, macrophages were pulsed for 2 hr with 50 JJl
(5J.1Ci) of Na 2 51 Cr0 4 '

The wells were washed three times to re move unbound

5 1 Cr and then 100 J.I1 of 1 NaOH was added and incubated for 5 min at room
temperature. This was repeated and samples were radioassayed using a LKB
gam ma counter (all samples were run in triplicate).

Bo rdetella lysates were a

gift from Alison Weiss (Department of Microbiology, University of Virginia,
Charlottesville).
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Tumoricidal assay.

The activation of resident or TG-elicited macrophages for

tumoricidal activity was determined using the C 3H/HeJ fibrosarcoma, L929, as
target cells (67).

Adherent peritoneal exudate cells (5x10 5 ) were placed into 2 4

well tissue culture plates with dilutions o f T-3, T-9 or Y -IFN.

After 2 4 h r the

wells were washed twice with warmed media and cultured with 5x10 4 3 H -TdR
labelled L929 target cells. After an additional 24 hrs, 5 llg DNase was added 2 0
m in prior t o harvesting the supernatants to facilitate the release o f radioactivity
from killed target cells (1 29) and 0.5 ml of each culture supernatant was
removed and then placed in 10 ml of Beckman redi-solve scintillation cocktail.
All sa m ples were run in triplicate and assayed using a liquid scintillation counter

(2 min, 296 error).
Induction of macrophage-mediated tumor cell cytostasis.
from T-3 and T-9, or cloned

Diluted supernatants

Y-IFN were compared for their ability to activate

resident or TG-elicited macrophages for tumor cell cytostasis. Adherent PEC's
(1x10 5 )

were

either

incubated for 24

hrs with

LK or

LK was added

simultaneously with the addition of 1x10 4 B16F10 melanoma target cells. After
an additional 2 4 hrs, the cells were washed twice with warm DMEM and the cells
were pulsed for 24 hours with 1 \1Ci 3 H-TdR.

Wells were harvested using a

M ASH cell harvester and assayed using a liquid scintillation counter (2 m in, 296
error) (53). Percent cytolysis was calculated by the formula:
Cytos tasis (96)

=

expe ri mental CPM X 100
control C P M

Experimental CPM: B 1 6 F 1 0 target cells and macrophage; control CPM: B 1 6 F 1 0
tumor cells in the absence of macrophage.
Kinetics for the induction of tumor cell cytostatic activity by LK.

Adherent,

thioglycollate-elicited macrophages (1x10 5 ) were added in 100\11 to 96 well
plates.

Macrophages were treated with 1 :1 0 dilutions of T cell hybridoma
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supernatants (T-3 or T-9) or I O U of cloned y -IFN for 0, 6, 1 2, 18, and 24 hr. At
the end of each incubation period, 1 x 10 4 B16F10 melanoma target cells were
added.

After an additional 24 hr

incubation, the cells were given 24 hr pulse

with 3 H-TdR (lIlCi/well) and assayed as described.
Induction of Ia-antigen expression.

The T-cell hybridoma supernatants were

screened

induce

for

their

ability

to

la

antigen

expression

using

TG elicited PEC's (Sx10 S cells/100 Ill.) were adhered on

im munofluorescence.

glass slides and fixed for I S min using 1 % paraformaldehyde. Macrophages were
then washed in DMEM (S% rabbit serum) and after 20 min fresh DMEM (S%
rabbit serum) containing a 1 :80 dilution of the monoclonal antibody 10-2.16 (anti
I-Ak) was added for 40 min at 40C.
twice with cold media.

Unbound antibody was removed by washing

Next, media containing a 1 :3 0 dilution of fluorescein

conjugated goat-ant i-mouse antibody (heavy and light chain specific) was added
at 40C for an additional 40 min.

Cells were again washed twice to remove any

unbound antibody and analyzed using epiilumination.
Determination of ectoenzyme profiles. Resident or TG-LK-treated macrophages
(lx10 6 ) were lysed in 1 .0 ml of O . O S% triton X-100 and then frozen at -200C.
Alkaline phosphodiesterase I (APD-I) activity was determined by taking 100 III of
the macrophage lysates and aliquoting into disposable glass 1 2x7S mm tubes
along with the substrate, loS m M p-nitrophenyl thymidine-S'-monophosphate
(prewarm ed to 370C). The samples were mixed well, covered with aluminum foil
to protect from light, and then incubated at 370C water bath. After 30 min the
sa mples were placed on ice and the reaction stopped by the addition of 1 .0 m of
0. 1 N NaOH and vortexed.

Absorbances were determined using a Beckman

spectrophotometer at 400 nm (24).
S OO III of 0.018 m M

To determine S' nucleotidase activity (S'N),

3 H - A M P substrate was added t o 100 II I o f macrophage

lysate and incubated at 370C in a water bath, shaking every 10 min.

After 30
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min the samples were placed on ice and the reaction stopped by adding 200 \.ll of
0.25 M ZnS04 and vortexed, followed by the addition of 2 0 0 III 0.25 M Sa (OH) 2
and vortexing once again. Samples were then centrifuged at 1 0 0 0 x g for 30 min
after which 500 III of the supernatant was added to 1 0 mls of Beckman redi-solve
scintillation fluid and each sample was counted in a Beckman scintillation
counter (23). Resident and TG-macrophages were then compared for changes in
API and 5'N activity.
Transferrin binding.
(Biorad).

Transferrin was iodinated using enzy mobead reagents

Briefly, transferrin was

radioiodinated with lactoperoxidase and

glucose oxidase coupled to agarose beads according to the manufacturer's
instructions. Na 1 2 5 I (LO rn cn was added to the reaction along with the protein
to be labelled.

The reaction was allowed to proceed for 2 5 minutes at RT and

then the contents of the vial were placed on a Sephadex G-25 column and
centrifuged at 1 0 0 x G for 2 minutes.

The effluent was collected in a

polystyrene test tube and diluted with 1.0 ml of PBS and 2 lIi was counted in a
LBK gamma counter to determine the CPM/llg protein. A TCA precipitation was
done to determine the efficiency of labelling. To assay for transferrin binding, 1
x 10 6 resident or TG-macrophages were cultured in 24 well plates in DMEM
alone or in the presence of Y -IFN, T-3 or T-9.
twice with Hanks (BSA 1 mg/ml).

After 24 hr wells were washed

125 I-Iabelled transferrin (2 nmoles) was then

added to 1.0 ml Hanks buffer along with a 1000 fold excess of unlabelled
transferrin.
buffer.

Plates were incubated at 40C for 1 hr and then washed twice with

This was followed by the addition of 0.1 N NaOH (0.5 ml) which was

allowed to stand overnight at 40C. Results were determined using a LKB gamma
counter. All samples were run in triplicate.
Recombinant

Y -interferon.

The recombinant mouse Y -IFN used in this study

was generously supplied by Patrick W. Gray (Genetech, South San Francisco,
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CA), and was produced from monkey C05-7 cells transfected with a plasmid
containing the murine

Y -IFN gene expressed under control of the SV40

promoter. Supernatants contained 19,000 units/ml as determined in a cytopathic
effect

inhibition assay using encephalomyocarditis

virus

on

L929

murine

fibrosarcoma cells (33).
Anti-y-interferon.
Johnson

The rabbit anti-mouse y-IFN was a gift from Howard M.

(Dept. of

Comparative and

Expt.

Pathology,

Univ.

of Florida,

Gainesville) and was produced by stimulating spleen cells with staphylococcal
enterotoxin A as described earlier. The serum titer used in this study contained
antibody sufficient to neutralize 1,000 units of
Neutralization studies.

'f-IFN/ml (88).

The effects of anti-y-IFN on LK activation of TG

elicited macrophages for B16F10 tumor cell cytostasis was determined. Diluted
supernatants from T-3 and T-9 (1 :5, 1 :10, 1 :20) were added to 1x10 5 adherent
PEC's along with antibody sufficient to n eutralize 10 U of y-IFN activity. After
24 hr lx10 4 B 1 6 F 1 0 melanoma target cells were added and the ability of anti-y 
IFN to inhibit macrophage cytostatic activity was determined.
Molecular characterization of T-3 and T-9.

In order to establish the protein

nature of the LK's, supernatants were incubated at 5 60C, for 3 min, 800C or
1000C for 5 m in.

Supernatants were also treated with 6.5 units of immobilized

Q-chymotrypsin (Sigma) for 1 hr.

Treated supernatants were then assayed for

cytostatic activity. The molecular weight range of T-9 was determined using an
Amicon filtration system. Using a ym30 (mw. cut off 3 0 K) and a ym10 (mw. cut
off 1 0 K) filter, three fractions were collected: (a) � 3 0,000, (b) 2 10,000 ::. 3 0,000,
(c) .:: 1 0,000.

These fractions along with unfractionated supernatant were then

assayed for cytostatic activity.
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RESULTS
Screening of T-cell hybridomas. Supernatants from the T-cell hybridomas were
collected and initially screened for their ability to protect against the cytotoxic
effects of Naegleria lysate, increase tumoricidal activity, and induce Ia-antigen
expression in resident and TG-macrophages.
Supernatants from 5 of the 16 cloned cell lines (T-2, T-3, T-6, T-9, T-13)
were able to significantly lower Naegleria lysate induced cytotoxicity in resident
macrophages (Fig. 2A).

Supernatants from clones T-2, T-3, T-6, and T-1 3

induced tu moricidal activity in TG macrophages, while this population appeared
to be unresponsive to T-9 supernatants (Fig. 2B). Only three (T-3, T-9, T-1 3) of
the original clones with activity protecting against Naegleria lysates also
induced Ia antigen expression in TG-macrophages (Fig. 2C). Based on thse three
activity patterns were selected T-3 and T-9 for further characterization.
T-3 and T-9 were both maintained in DMEM and 10% FCS and gradually
adapted to HB101 serum free medium.

Both clones continued to produced

sufficient LK in either media (serum-free supernatants were designated 3HB and
9HB).
T-cell hybridoma division times. Both hybridomas T-3 and T-9 were observed to
double in number every 24 hr.

Cell number increased from the initial 1x10 6

cells/ml to 1.8x10 6 after 24 hr, 4.1x10 6 cells/ml at 48 hr, and 12.8x10 6 at 72 hr.
(Fig. 3).

The growth of both T-3 and T-9 was particularly density dependent

which may explain why cellular division proceeded at a slightly increased rate
between 48 and 72 hr.
IL-2 determ ination. None of the culture supernatants screened contained any IL2 activity relative to the positive controls containing TCGF (Table 1).

At all

three dilutions, one of the T cell supernatants were able to induce a proliferative
response as determined by the uptake of 3 H-TdR.
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Fig. 2. Screening of cloned T cell hybridoma supernatants. A. Protection
of resident

macrophage agai�t destruction crude Naegleria fowleri

Adherent peritoneal macrophage (3 X 1 0 5 ) were co-cultured with

lysate.

3 X 1 0 4 equivalents of crude lysate and a 1 :2 d ilution of crude hybridoma
supernatants.

After 18 hr, macrophage were given a 2 hr pulse with

Na 2 5 1 Cr0 4 ' Unbound 5 1 Cr was washed free and viable macrophage were
lysed in I N NaOH.
counter.

B.

Triplicate samples were assayed using a LKB gamma

Activation of TG-elicited peritoneal macrophage for

tumoricidal function.

TG-macrophage were

cultured 24 hr with 1 :1 0

dilution o f the hybridoma supernatants. Supernatants were removed and 5
X 104

3 H -TdR labelled

L929 cells were added for an additional 24 hr.

Prior to harvesting 5 J..lg DNase was added and then 0.5 ml of culture
supernatant was assayed.
released.

C.

Results are presented as percent

Induction of la-antigen expression.

3 H -TdR

TG-macrophage (5 X

1 0 5 /1 0 0 Ill) were treated for 24 hr with hybridoma supernatants and then
adhered to glass slides and fixed in 1% paraformaldehyde.

Macrophage

were washed and a 1 :3 0 dilution of a monoclonal antibody 10-2.16 (anti-I
Ak ) was added, followed by the addition of fluorescein-conjugated goat
anti-mouse

antibody

(diluted

1 :30).

Cells

were

analyzed

using

epiilumination and expressed as 96 of total population expressing Ia
antigen.
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Table 1 . Assay for IL-2 activity in T cell hybridoma supernatantsa

SAMPLES

MEDIA

C P M +/-S.D. (% v/v condition media)
50
25
12.5

6.25

1-4

3 Sb

334 + 99

5 8 5 + 195

798

5-8

3 HB c

348

84

357

+

19

405 +

73

9-1 2

9S

240 + 4 8

429

+

108

474

55

518

+

155

1 3-16

9 HB

868 + 46

912

+

150

943 + 2 1 8

887

+

159

1 7-2 0

TCGF

15315

+

736

13656

+

1027

21

none

+

1 2 3 5 5 + 2 38
279

+

301

+

+

19372 + 1808

391

+

70

51 + 290

109

a IL-2-dependent C10 cells w ere cultured a t 1X10 4 along with serial dilutions of
T-3, T-9, or TCGF. Cells were pulsed with 1 \lCi 3 H -TdR for an additional 24
hr and then harvested on a M ASH cell harvester and assayed using a liquid
scintillation counter.
bSupernatants were obtained from cultures grown in DMEM

+

10% FCS.

c Supernatants wre obtained from cultures grown in HB101 serum-free media.
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Induction of hybridoma-derived LK.

While it has been demonstrated that the

addition of Con A to hybridoma cultures can increase production of LK (84), this
was not the case for T-3 or T-9.

The addition of ConA did not result in any

significant differences when compared to untreated cultures.

Dilution of the

supernatants did not show any differences in the cytostatic activity induced in
the treated macrophages. Both the treated and untreated supernatants produced
maximum cytostatic activity at 1 :10 and 1:20 dilutions (Fig. 4). The length of
exposure to ConA did not effect LK production as treatment for 24 hr (data not
shown) or 48 hr yielded similar results.

Varying the cell number also did not

produce a differential response to ConA (data not shown).
Macrophage protection against Naegleria fowleri.

The ability of T-3 and T-9

supernatants to protect resident macrophages against the cytopathic effects of
live Naegleria and Naegleria lysates were compared.
resulted in the specific release of
Naegleria in the absence of LK.

Resident macrophages

less than 10% of the

3 H -uridine labelled

When cultured in the presence of T-3 or T-9,

resident macrophages mediated the speCific release of 42% and 43% of the 3 H uridine label respectively (Fig. 5) (spontaneous release was les than 6%). T-3 and
T-9 LK's also protected resident macrophages from destruction by Naegleria
lysates.

Resident macrophage destruction was decreased by 15% and 24% upon

the addition of T-3 or T-9 supernatants (Fig. 6).

The cytostatic activity (anti

proliferative effect as determined by 3 H -TdR uptake) in the same population of
resident macrophages towards

B16F10 target cells however was low .

This

activity could not be increased by the addition of T-3 or T-9 supernatants (data
not shown).
Cloned y-IFN was unable to offer similar protective mechanism to resident
macrophages. Ten units, of y -IFN had no effect on cytotoxicity in lysate-treated
resident

macrophages.

Regardless of the

target/effector ratio (resident
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Effects of LK and LPS o n Resident M (Z) Cytotoxicity
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Fig.

5.

:v1 a c r ophage-des truction
incubated

for

of

24

Naegleria

macrophage

w ere

supernatants

( 1 :1 , 1 :2, 1 :8) follow ed by the addition of

uridine labelled ]i. fowleri target cells.

hr

with

Resident

fowleri.

d iluted

T-3
2 X

and

104

T-9

3H

-

A fter an a d d i tional 2 4 hr, 1 0 0 )11

of each c ul t ur e d supernatant was r e :n oved and a dded to 3 ml scintillat i on
cocktail a n d assayed using a scintilla tion counter (all sa m ples w ere run in
triplica te).
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Effect of LK on N. Fowleri Lysate Induced
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E f fect of T cell hybrid o m a-derived L K on the destruction of

ma crophage by N a egleria fowle r i lysa tes.

Resident macrophage w e r e

cultured a t 3 X 1 0 5 /well w i t h a 1 :2 d ilution o f T-2, T-3, o r T-9 L K . A fter
24 hr 3 X 1 0 4 N a egleria equivale n t s w ere added for a n addi tional 18 hr.
M a cr ophage were pulsed w i th 2 hr w i th 5 4 C i 5 1 Cr/well.
w as washed fr e e a n d viable cells lysed i n 1 N N a O H .
were assayed using

a

L K B ga m m a counter.

U n bound 5 1 Cr

Triplicate sa m ples
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macrophages: Naegleria equivalents), Y -IFN did not appear to influence their
vulnerability

to

Naegleria

lysates

(Table

2).

Thioglycollate�licited

macrophages were also sensitive to the cytotoxic effect of lysate and as seen
with resident macrophages, the addition of Y -IF N was unable to prevent their
destruction.

(Table 2). Unlike resident macrophages, which were not activated

for tumor cell cytostasis

by LK (T-3, T-9, Y -IFN), Y-IFN treatment of TG

macrophages resulted in increased activity directed against B16F10 melanoma
cells (Table 3).
Macrophage protection against Bordetella pertussis. The ability of recombinant
Y-IFN to protect TG-macrophages against the cytopathic effects of Bordetella
pertussis (strain BP338) lysates was also determined.

At all target (TG

macrophages)/effector (BP3 3 8 lysates) ratios tested, Y -IFN was unable to offer
protection (Fig. 7). Both Y -IFN-treated and untreated macrophages were equally
susceptible to the cytopathic effects of lysates.
TG-macrophages

by

BP338

lysates

is

density

This observed destruction of
dependent.

Using

3x10 5

macrophages, 5 7 % of the untreated macrophages and 51% of the Y -IFN-treated
macrophages were killed.

This increased to 69% and 66% respectively with

1 . 5x10 5 macrophages and 90% and 92% using 3x10 4 cells .
Kinetics for the induction of cytostatic activity by T cell LK.

In order to

determine the exposure time to T-3 and T-9 required to produce maximal
cytostatic activity, TG-macrophages were exposed to LK for various time
periods between 2 4 and 48 hr. All macrophages were exposed to target cells for
the same period of time (24 hr).

Exposure of macrophages to LK for 24 hr

induced cytostatic activity in TG-macrophages (Fig. 8). This activity remained
cons tant over the next 48 hr, as further exposure was unable to increase activity.
Alteration of ectoenzyme profiles. Several inves tigators have associated plasma
me mbrane ectoenzyme levels with differentiation or activational changes in
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Table 2. Effect of recombinant 't-IFN on the destruction of macrophage by
Naegleria fowleri Lysates

% Macrophage Destruction ( 51 Cr Uptake)
Macrophage/
Resident Macrophal!:e
Naegleria Equivalentsa
medium

HFN (10 U)

Thiogl;icollate Macrophage
medium

Y-IFN (10 U)

3XI0 5 /3 X I 0 4

21

+

15 b

17

+

12

20

+

4

14

+

3

1.5XI0 5 /3 X I 0 4

22

+

12

29

+

8

22

+

8

23

+

3

3XI0 4 /3 X I 0 4

26

+

6

15

+

7

30

+

12

26

+

7

a Macrophage were cocultured with Naegleria lysates for 18
with 5jJCi of 51 Cr, and lysed with 1 N NaOH.
b Mean + standard deviation.

hr,

pulsed for 2

hr
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Table 3. Enhance ment of tumor cell cytostasis by recombinant Y-IFN

% Cytostasis ( 3 H -Tdr Release)

Resident Macrophage
Macrophage /B l 6 Fl o a medium
l X 1 0 5 /1 X 1 0 4

11

+

5XI04/1XI04

0

l X 1 0 4 / 1 X 1 04

0

'f-IFN (10 U)

5b

0
18

+1
0

Thioglvcollate Macrophage

medium

Y-IFN (10 U)

66

+9

76

+3

64

+

1

80

+1

18

+ 10

78 + 2

a Macrophage were treated with recombinant 'f-IFN for 24 hr and wells were
washed 3 X to remove excess LK prior to the addition of B16FI0 target cells.
Cultures were incubated an additional 2 4 hr followed by a 24 hr pulse with
I 11Ci 3 H -TdR. Wells were harvested using a M ASH cell harvester and asayed
using a liquid scintillation counter.
b Mean

+ standard deviation.
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CYTOTOXI C EFFECT OF 80RQETFII A
lYSATES ON THIOGlYCOllATE t19
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Fig .7 . Effect of cloned gamma - Interferon on the destructton

of T6-t18 by BonIetelJa pertussIs ( BPJJ8, wtld type ) Iysates.
T6-el lclted Me were cultured w ith 1 0 Wilts gamma- Interferon
Arter 24 hr l 00JiI ofBordetelta lysate ( 4SJiglml protein ) was

added for an add l ttonal 18 hrJ1S were pulsed for 2 hr w i th 5 JiCI
S i er I wen. Unbound S l er was washed tree and viable cens
lysed In IN NaoH.
gamma counter.

TrlpHcate samples were ISsaYed using a lBK
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(•)

Fig. e . Kinetics for the Induction of cytostatic activity by T
cel l lK. Thloglycollate - elicited t1S O x t 0 5) were added to 96
wel l plates and treated w i th T cel l hybrldoma supernatants or
cloned gamma-Interferon for 0,6, t 2, t e,and 24 hr. At the end or
each Incubat ion period. I X 1 0 4 B 1 6f t O me lanoma target cel ls
were added.
Arter an add I tional 24 hr, cells were pulsed w i th

I pCI (JH1-TdR and harvested and assayed

as described.
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m acrophage populations and have de monstrated changes in the ectoenzy me
levels in tu moricidal macrophages ( 1 9 , 2 1 , 7 0 ).

W e therefore chose to determine

the effects of T-3 and T-9 on A P D-I and 5'N activity.

Resident m acrophages

initially had lower APD-I activity but higher 5'N activity as compared with TG
macrophages.

After treatment with T-3 or T-9 for 24 hr there were no

significant changes in APD-I or 5'N levels in either macrophage population (Fig.
9, 10).
Because T-3 exhibited the capability to induce tumor cell cytotoxicity and
cytostasis, protect against the cytopathic effects of Naegleria fowleri lysates,
and induced Ia expression, but did not alter ectoenzy me profiles at 24 hrs, we
decided to observe the kinetics of T-3 modulation of ectoenzy m e levels in
Alkaline phosphodiesterase I activity was

resident-macrophages (Fig. 1 1 , 1 2).

observed to decrease during the first 4 hrs.

Between 4-12 hrs there was an

increase in T-3 treated cells, while activity continued to decrease in untreated
resident-macrophages.

At 24 hrs, activity levels were not significantly higher

than the untreated controls.
The 5'N activity was also observed to decrease rapidly in T-3 treated and
untreated resident macrophages during the first 4 hrs.

Activity leveled from 4-

1 2 hrs, but continued to decrease in both treated and untreated cells.
Expression of transferrin receptors.

Recent findings have shown that the

expression of transferrin receptors m ay be a useful marker of the responsive
stage for macrophage functional activation (37, 1 3 1 ).
to determ ine the effects of T-3
We

transferrin receptors.
significantly

higher

quantities

macrophages (Table 4).
transferrin.

found
of

For this re ason we wanted

and T-9 supernatants on the number of
TG-elicited

macrophages

1 2 5 I-transferrin

initially

co m pared

to

bound

resident

Untreated resident macrophages bound 17 pi co moles of

When treated with T-3 or T-9 the number of pico moles bound
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Effect

phosphod i esterase
m a c r ophages.
d ilutions o f

0.05%

I

T

cell

activity

Resident and

in

hybr idoma
resident

9HB

l y m pho�: ines

and

on

alkaline

t h ioglycollate-fecrui ted

TG macrophage s were t reate d with 1 : 1 0

T-3 o r T-9 hybridoma super na ta n t s conta i n i ng seru m ( 3 , 9 ) or

w i thout seru m
of

of

9

3HB

3

( 3 HB, 9 HB). After

t r i t on

X-I O O .

24 hr, l X l 0 6 c ells w e r e lysed in 1 . 0 ml

Alkaline

phosphod i es ter&se

d e t e r m ined as descr ibed in Mater ials and M e t hods.

I

levels

w ere
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E F F E C T OF T - C E L L H Y
B RIDOMA LYMPHOKINES
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1 0.

activity.

3

3HB

E f fect of T cell hybr i d o m a

9

9HB

ly mphokines on 5 'n u c leotidase

Resident a n d T G-recr u i t e d ma crophages were t re a t e d w i t h 1 : 1 0

diluti ons o f T -3 o r T -9 hybr idoma supernatants contain ing seru m ( 3 , 9 ) or
w i t h o u t ser u m ( 3 H B , 9 H B).
o f 5 ck;, t r i t o n X -I 0 0 .

After 2 4 hr, 1 X 1 0 6 cells w ere lyse d in 1 . 0 ml

5 'nucleot idase levels w e re d e t e r m ined a s descr ibed in

il1 a t e r ials a n d :'I1 e t h ods.
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Effects
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macr ophages were t reated for 4, 8, 1 2 , 1 6 , a n d 24 hr with 1 : 1 0 d iluti ons o f

T-3 supernatant ( w ith or w i thout

5 �g LPS).

A fter the speci fied peri0:i5,

I X I 0 6 c e lls were lysed i n 1 . 0 ml of 0 . 0 5 % triton X-I O O and assayec
describe d in Materials and M e thods.
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Table 4. Transferrin binding by resident and
thioglycollate-elicited peritoneal macrophage a

Transferrin Bound (pico moles)

Treatment

Resident Macrophage

Thioglycollate Macrophage

medium

1 7 .4 + 0.5

26.1 + 1.6

T-3

2 4. 6 + 0. 7

2 7 . 1 + 1 .8

T-9

2 1 .0 + 2.4

31.3 + 0 . 1

Y-IFN

13.4 + 0.9

2 3. 4 + 1 . 3

aTransferrin binding w a s determined i n t h e presence o f 2.0 n moles 1 2 5 1_
labelled and 2 0 0 0 nmoles of unlabelled transferrin after 1 hr cells were
washed 3 times and lysed i n O. l N NaOH.
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increased to 2 5 and 21 respectively.

Gam ma-IFN

induced a slight decrease in

the number of moles bOWld by resident macrophages.

When TG-macrophages

were treated with T-3, no significant increase was observed in transferrin
binding. However, elicited macrophages treated with T-9 showed an increase in
the number of transferrin receptors and bound 31 pica moles.

As seen with

resident macrophages, Y -IFN produced a slight decrease in the number of moles
of transferrin bOWld.
Serological characterization.

Antibody capable of neutralizing the anti-viral

activity of 1 0 Wlits of Y -IFN was able to neutralize a 1 :5 dilution of T-9
supernatant and prevent the induction of cytostatic activity in TG-macrophage
populations

against B16F10 melanoma cells.

While inducing a 37% increase in

activity over the media control, T-9 activity was reduced to les§ than 20% in the
presence of anti-Y-interferon (Fig. 1 3).
unaffected

by

antibody,

maintaining

T-3 supernatants appeared relatively
high

levels

of

activity

( 55%),

demonstrating that the activity contained in T-3 supernatants is due to a Wlique,
non-gam ma-IFN molecule.
Characterization of lymphokine activity.

A standard cytostatic assay, utilizing

TG-macrophages and B16F10 melanoma target cells, was used to determine the
heat stability and molecular nature of T-3 and T-9 LK.

Treatment of

supernatants at 560C for 3 0 min did not effect T-3, but eliminated the ability of
T-9 to induce cytostatic activity in TG-macrophages completely. Incubation at
800C for 5 min lowered T-3 activity to less than 1 0% and at 1000C for 5 mins all
activity was lost (Fig 1 4 A).

Both T-3 and T-9 were totally inactivated by

(l 

chymotrypsin (Fig. 1 4B). T-3 and T-9 increased tumor cytostatic activity in TG
macrophages by approximately 38-40% as compared to the medium control.
After proteolytic treatment neither supernatants showed any activity.

The

cytostatic activity of T-9 LK was fOWld in two a micon filter separated fractions.
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E F FE C T OF ANTI - G A M M A I NTERFERON ON THE
A B I L I T Y O F LK T O I N D U C E C Y T O S T A S I S
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1 3 . Neu tralization of T cell hybridoma d e rived ly m phokines by

ga m m a i nt e r feron specific a ntibody.

T G- m a cr ophage

cultur e d in the presence of T-3 and T-9
sufficient to n e ut ralize

10� of

(1

X

10 5) were

LK ( d iluted 1 :5) and antibody

-IF N. After

2 4 hr wells were washed and

1 X 1 0 4 B1 6 F10 m elanoma target cells were added a nd cytos tatic activity
d e t e r m i n e d . Bars represent mean percentages

( � s tand ard deviation).
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Fig. 14. C haracterization

of T cell

hybridoma derived lymphokines.

A. Heat inactivation of T cell hybridoma derived lymphokines T-3 and T9.

Supernatants from T-3 and T-9 were incubated at 560C for 3 0 min,

800C or 1000 C for 5 min.

After heat treatment supernatants were

assayed for their ability to induce tumor cell cytostasis in TG-elicited
macrophages as described in Materials and Methods.

B.

Proteolytic

inactivation of T cell hybridoma derived lymphokines T-3 and T-9.
Supernatants were treated with 6.5 units of i m mobilized a-chymotrypsin
for 1 hr.

Carboxymethyl cellulose beads were removed by centrifugation

at 4 0 0 x g for 30 min.

Treated supernatants were then assayed for the

induction of cytostatic activity in TG-macrophages. C. Molecular weight
determination of T-9 derived lymphokine.

Supernatant from T-9 hybrids

grown in HB101 serum-free m edium were fractionated using an Amicom
filtration system and a ym 30 (mw. cut off 3 0K) and a ym10 ( mw. cut off
1 0 K).

Three fractions were collected: (a) � 30,000 (b) 2. 1 0,000 ::.. 30,000,

and (c) :.. 1 0,000.

These fractions were screened for the induction of

cytostatic activity in TG-macrophage.
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Both the 1 0-3 0,000 molecular weight fraction and the less than 10,000 fraction
contained activity comparable to the unfractionated sample.
30,000 fraction showed no activity (Fig. 14C).

The greater than
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DISCUSSION
The role of T cell derived lymphokines as modulators of macrophage
phenotype and function is well documented (13,1 0 3, 1 1 3). We chose to screen our
hybridoma supernatants based on known

Y-IFN activities: the ability to increase

tumoricidal activity and the expression of Ia antigens in peritoneal exudate
macrophages.

Purified Y -IFN has been shown to increase Ia expression in a

concentration dependent fashion (10,105,1 19,128), while Cl-IFN and �-IFN result
in minimal increased Ia expression (96,105,137). Cloned or hybridoma�erived Y 
IFN has also been well documented to prime murine macrophages for tumoricidal
activity (16,33,89). While Cl-IFN/� -IFN also show tu moricidal activity, y-IFN has
been reported to be approximately 850-1,000 times more effective at activating
macrophages (89,95).

Earlier findings, that mouse peritoneal macrophages co

cultured with the opportunistic pathogen, Naeglerill fowleri were killed within 18
hours, ( Marciano-Cabral, unpublished data) lead us to screen our supernatants for
LK's that would offer protection.
Macrophage activation as determined by screening, appeared to correlate
with the dilution of supernatant; however, it was important to maintain the
grown of T-3 or T-9 in log phase and with high viability (80%) to insure maximal
and consistent production of LK.

Both hybridoma cell lines demonstrated

doubling times of 1 8-24 hr and were constituitive producers of lymphokines as
indicated by the inability to increase LK production by stimulation with Con A.
Supernatants were also screened for IL-2 (TCGF) production. Neither T-3 or T-9
demonstrated any IL-2 activity as determined by their inability to induce a
proliferative response in the IL-2 dependent CI0 cell line (Table 1).
Functionally, the activation of macrophages has been defined in terms of
microbicidal and tumoricidal activity (31,37,47,61). Recent attempts have been
made to define discrete stages of activation.

The terms resident, responsive,
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primed a n d fully activated have been employed t o describe the level of
activation with regards to tumoricidal activity, and the m ethod of elicitation
(37,47).
These

macrophage

have been shown to exhibit biochemical markers

justifying this categorization (13,37,47,70,102). We have found that resident and
TG-elicited peritoneal macrophages responded quite differently to T-3 and T-9
supernatants when examined for cytostatic and cytotoxic activity directed
towards tumor cell targets.
cytostatic
populations.

activity

in

Both T-3 and T-9 were capable of inducing tumor

TG-macrophages

but

not

in

resident

macrophages

While T-3 activated TG-macrophages for tumoricidal functions (but

not resident macrophages), T-9 was inactive in both macrophage populations.
Kinetic stUdies using B16FI0 melanoma target cells show that development of
cytostatic function in TG-elicited macrophages requires approximately 24 hr of
exposure to LK (T-3, T-9, or Y -IFN).

While the level of activity achieved

appears to vary according to the LK employed and the length of exposure, it is
difficult to determine whether this is due to the intrinsic nature of the molecules
(as seen between

Q-,

a -, and y-IFN) or because of variability in LK secretion by

the hybridoma cultures.

However, we attempted to avoid the latter possibility

by pooling supernatants.
The finding that both T-3 and T-9 were capable of inducing protective
mechanisms against Naegleria lysates in resident but not in TG-macrophages
offers more evidence of functional differences between these populations.
inability of cloned

The

Y -lFN to protect either resident or TO macrophage supports

the finding that MAF ( Y -IFN) inducing tumoricidal activities are different from
those inducing anti-parasitic activities (51,13 5).
A dissociation between tumor cytostatic and bacteriocidal mechanisms has

also been shown ( 3 1 , 61 ). We, therefore, decided to look at the ability of Y -IF N to

63

protect TG-macrophages from Bordetella lysates.

!!. pertussis, strain BP338

(wild type), contains high levels of adenylate cyclase. This enzyme is thought to
impair host defense mechanisms by entering phagocytic cells and converting ATP
into cyclic A M P, a known inhibitor of phagocytosis (17). Results were similar to
those obtained in the Naegleria model with

Y-IFN unable to prevent TG

macrophage destruction.
A recent report indicates that human T cell clones, specific for a purified
Mycobacterium tuberculosis antigen, release a form of MAF which is not
neutralized by m onoclonal antibody against Y -IFN (8).
at

high

concentrations,

recombinant

Y -IFN

Others have shown that

failed

intra macrophage replication of M. tuberculosis and

to

prevent

the

actually caused increased

mycobacterial replication and macrophage destruction (21).
The cytopathogenicity of Naegleria fowleri for a variety of mammalian
cells in vitro has been demonstrated (64); however, the mechanism by which the
amoeba exerts this effect remains an enigma.

It has been suggested that B..

fowleri ingests target cells by phagocytosis or by drawing in small portions of the
target cell plasma membrane until the integrity of the membrane is disrupted

(64).

Other investigators have suggested that a cytopathic toxin or enzyme

(phospholipases) are released (19,122). Most investigators are in agreement that
some type of cell contact is required for target cell injury (64,1 22).
W e have found that live Naegleria and lysates were able to mediate a
cytopathic effect in both resident and TG-macrophages in an 1 8-hr assay.

These

findings suggest the presence of a cytotOXiC factor(s) which is either present on
the membrane surface or is secreted from lysosomes or vesicles upon contact
with target cells.

Curson

et al. (19) has shown that

phospholipase

2-

lysophospholipase enzymes are found in the supernatants of axenically grown B..
fowleri

and

that

hyperimmune

rabbit

antisera

prepared
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against these enzymes could prohibit or delay the cytopathic effects of live
Naegleria in Vero cell cultures.
It is particularly interesting that a unique non-gamma interferon L K
(derived from T-3 and T-9) is capable of protecting resident macrophages from
Naegleria lysates but does not alter the effects on TG-macrophages.

The

observed change in susceptibility does not involve APD-I or S'N ectoenzyme
expression since we did not detect any significant changes in the levels of these
ectoenzymes in treated and untreated macrophage populations over 24 hr.

It is

possible that T-3 and T-9 induce the modulation of a receptor for the cytolytic
substance from the surface of resident macrophages while not affecting TG
macrophages.
This difference in responsiveness to LK could also be due to the particular
stage of the cell cycle in which TG-macrophages and resident macrophages are
found. Sorg et al. ( 1 1 2 , 1 1 3,1 14) has suggested that as macrophages differentiate
from bone marrow precursors in the presence of CSF (colony stimulating factor)
there is an intense phase of proliferation. Some macrophages continue to cycle
and accumulate in late G l '

These macrophages are functionally capable of

responding to a wide variety of LK and chemotactic factors as well as producing
interferon ( 1 1 3). As proliferation begins to slow the cells differentiate in G l and
lose most of these functions as they enter into G O '

Resident macrophages are

thought to be in G O , while TG-macrophages are found in late G l (1 1 2,1 1 3,114).
According to this model, resident macrophages m ust pass from G O into late G l in
order

to

become

( 1 1 2,1 1 3, 1 1 4).

activated

for

tumoricidal

Lymphokine (T-3, T-9 or

or

bactericidal

functions

Y-IFN) alone is not capable of pushing

resident macrophages from G O to late G l and therefore they do not display
tumoricidal functions.

Thioglycol1ate macrophages, already present in late G l ,

are induced to kill tumors with the addition of LK.
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It has been shown that the number of transferrin receptors in TG
macrophages is higher than in resident macro phages.

After treatment with

y

IFN the number of transferrin receptors is markedly reduced; however, in
resident macrophages levels remain unaffected (1 31).

We obtained similar

results in TG-macrophages, and in resident m acrophages we saw only a slight
decrease in transferrin binding after exposure to y-IFN. These findings indicate
that resident m acrophages are unresponsive to y -IFN because they lack or
express very few receptors for this molecule. The failure of Y-IFN to alter the
cytopathic effect of crude Naegleria lysates on resident macrophages is in line
with this theory.

Both T-3 and T-9 supernatants induce unique transferrin

binding patterns in resident and TG-macrophage, distinct from y -IFN and appear
to act differentially on these macrophage populations.

Supernatant from T-9

increased transferrin binding in both resident and TG-macrophage populations,
while T-3 increased binding

in resident cells only and had no effect on TG

macrophages.
The protective mechanism induced by T-3 or T-9 in resident macrophage
populations could not be demonstrated in T G-macrophages using either LK.

We

speculate that macrophage in G O express receptors for the LK present in T-3 and
T-9 supernatants.

As these resting cells receive

signals

moving them

sequentially from early to late G l they begin to express receptors for y-IFN and
lose r eceptors for T-3 and T-9 supernatants.
W e have shown that TG-macrophages can effectively destroy tumor cells
after L K treatment (T-3, T-9, or y-IFN). The addition of LPS was not necessary
as a second signal but we can not rule out the possibility of low levels of
endotoxin in the culture media. These macrophages were unable to demonstrate
any lytiC effect or protection against Naegleria fowleri. Resident macrophages,
which are thought to be functionally down-regulated and unresponsive to LK
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signals (37,1 12, 1 3 1) did not demonstrate any tumoricidal activities.

However,

treatment with T-3 or T-9 was able to protect resident cells from Naegleria
lysates and induce amoebicidal activity, de
"J0nstrating a capacity to respond to
LK. This finding therefore demonstrates that resident macrophages may play a
role in effector functions.
The data in this paper supports earlier findings that lymphokines from
different T-cell clones can activate distinct macrophage functions (3 1 ). T-3 and
T-9 supernatants were shown to differ both serologically and biologically. The
molecular moiety in T-3 and T-9 supernatants responsible for the induction of
cytostatic activity is heat labile and sensitive to a-chymotrypsin and therefore
is not endotoxin, but more likely a protein or glycoprotein. Furthermore, T-9 LK
appears to have a molecular weight approximately that of y-IFN.
It

has been argued that

MAF and

y-IFN are one and

the

same

( 2 3 , 5 5, 89,106); however, there have been previously reported findings of cloned
hybridoma cell lines exhibiting MAF activity and no y-IFN activity (3 1 ). While it
is apparent

that )'-IFN induces many of the functional characteristics of

activation in macrophages, we offer supporting evidence that it is not the only
form of macrophage activating factor.

While both T-3 and T-9 supernatants

induce some macrophage functions associated with y-IFN (89,1 38) they also
contain activities not described to

Y-IFN.

Anti-Y-interferon is able to block

tumor cell cytostasis induced by T-9 supernatants but not by T-3 supernatants.
It can be concluded that this activity may be shared by both Y-IFN and a non- y
IF N LK.

This non-Y-IFN molecule is responsible for protection against the

cytopathic effects of Naegleria lysate.
Our data supports the fact that distinct T cell subsets produce different
lymphokines under various physiological conditions and that the effect these
lymphokines have on m acrophages depends upon the biochemical nature of the
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responding macrophage population. We have introduced evidence that the signals
for activation of macrophage populations in response to the protozoan, Naegleria
fowleri and the bacterium, Bordetella pertussis are distinct from activation for
tumoricidal activity, and appear to be

more closely associated

with the

activation of bacteriocidal and anti-parasitic mechanisms which are not Y-IFN
induced.

Furthermore, we have proposed an association between the cell cycle

and the responsiveness to specific L K.
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